Predictors of Orphan Drug Coverage Restrictions in Medicare Part D
The majority of orphan drugs are subject to utilization controls in Medicare Part D plans. The use of utilization controls varies by certain drug characteristics.
Change in Claims-Based Diabetes Medications Is a Diabetes Improvement Indicator
Without clinical information, a decrease in use of medications can serve as a proxy for clinical improvement.
Validating the Adapted Diabetes Complications Severity Index in Claims Data
The aDCSI without the inclusion of laboratory data performs similarly to the DCSI with laboratory results, and is a good measure of diabetes severity.
Predicting Costs With Diabetes Complications Severity Index in Claims Data
The Diabetes Complications Severity Index without laboratory test results is a good measure of diabetes severity, given its ability to explain costs.
